ClassID:

20952

A61K38/185 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3

Recent Application in this class:
#301
20160375098
2016-12-29

Mesenchymal stem cells for the treatment of CNS diseases

#302
20160367678
2016-12-22

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#303
20160361386
2016-12-15

Methods and compositions for inducing differentiation of human brown adipocyte progenitors

#304
20160346197
2016-12-01

Use of encapsulated cell therapy for treatment of ophthalmic disorders

#305
20160324924
2016-11-10

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

#306
20160279169
2016-09-29

GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS

#307
20160263189
2016-09-15

TREATMENT OF A NEURODEGENERATIVE DISEASE OR DISORDER

#308
20160250163
2016-09-01

Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms

#309
20160244757
2016-08-25

Compositions and methods for modulating neuronal excitability and motor behavior

#310
20160243028
2016-08-25

Auris formulations for treating otic diseases and conditions

#311
20160220639
2016-08-04

METHODS AND COMPOSITIONS FOR TREATING BONE DISEASES

#312
20160193296
2016-07-07

METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS

#313
20160193145
2016-07-07

Methods of delivering pharmaceutical agents

#314
20160168239
2016-06-16

Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders

#315
20160161470
2016-06-09

Modulation of axon degeneration

#316
20160158192
2016-06-09

Combination therapies for the treatment of Alzheimer's disease and related disorders

#317
20160158191
2016-06-09

Combination therapies for the treatment of alzheimer's disease and related disorders

#318
20160143993
2016-05-26

Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide mimetic

#319
20160136242
2016-05-19

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

#320
20160129246
2016-05-12

Method and apparatus for close-field electroporation

#321
20160095902
2016-04-07

Auris formulations for treating otic diseases and conditions

#322
20160060317
2016-03-03

NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE

#323
20160045564
2016-02-18

Therapeutic use of a growth factor, METRNL

#324
20160045487
2016-02-18

COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY

#325
20160038408
2016-02-11

METHODS FOR REDUCING ACUTE AXONAL INJURY

#326
20160033529
2016-02-04

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#327
20160030560
2016-02-04

Methods of treating neurodegenerative conditions

#328
20160022976
2016-01-28

Method and composition for hyperthermally treating cells

#329
20160022773
2016-01-28

Methods for promoting wound healing and hair growth comprising GDNF administration

#330
20150343080
2015-12-03

GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS

#331
20150343068
2015-12-03

GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY

#332
20150335587
2015-11-26

Cell lines and their use in encapsulated cell biodelivery

#333
20150313962
2015-11-05

Administration of growth factors for the treatment of CNS disorders

#334
20150290360
2015-10-15

Method of preparing an implantable neuroendoprosthetic system

#335
20150290291
2015-10-15

Solvent/polymer solutions as suspension vehicles

#336
20150283113
2015-10-08

Combination therapies for the treatment of Alzheimer's disease and related disorders

#337
20150283071
2015-10-08

Methods of delivering pharmaceutical agents

#338
20150265725
2015-09-24

Method and composition for hyperthermally treating cells

#339
20150252087
2015-09-10

Treatment of brain injury with a neurotrophic peptide

#340
20150246138
2015-09-03

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#341
20150238537
2015-08-27

Method and system for treatment of cardiovascular disorders

#342
20150238536
2015-08-27

Method and system for treatment of cardiovascular disorders

#343
20150238535
2015-08-27

Method and system for treatment of cardiovascular disorders

#344
20150238531
2015-08-27

Urine stem cells for skeletal muscle generation and uses thereof

#345
20150231208
2015-08-20

Treatment of allodynia

#346
20150217022
2015-08-06

Nerve regeneration employing keratin biomaterials

#347
20150203562
2015-07-23

Compounds and methods for modulating pharmacokinetics

#348
20150202269
2015-07-23

AAV-mediated gene therapy for RPGR X-linked retinal degeneration

#349
20150202263
2015-07-23

Neurturin molecules

#350
20150202262
2015-07-23

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

#351
20150198613
2015-07-16

Soluble MANF in pancreatic β-cell disorders

#352
20150182662
2015-07-02

Compositions and methods for treatment of cardiovascular disorders

#353
20150174072
2015-06-25

Microparticles supporting cells and active substances

#354
20150164994
2015-06-18

Systems and methods for angiogenic treatment in wound healing

#355
20150164990
2015-06-18

Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss

#356
20150141329
2015-05-21

Neurturin molecules

#357
20150119326
2015-04-30

Administration of angiocidin for arresting the growth of a tumor cell

#358
20150110875
2015-04-23

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

#359
20150086517
2015-03-26

Mesenchymal stem cells for the treatment of CNS diseases

#360
20150080299
2015-03-19

CONCENTRATED PROTEIN PREPARATIONS OF BONE MORPHOGENETIC PROTEINS AND METHODS OF USE THEREOF

#361
20150044259
2015-02-12

SCAFFOLD FOR ENHANCED NEURAL TISSUE REGENERATION

#362
20150023932
2015-01-22

ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF

#363
20150020222
2015-01-15

Neurotrophic factor MANF and uses thereof

#364
20150010497
2015-01-08

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

#365
20150005236
2015-01-01

USE OF BETA-NERVE GROWTH FACTOR FOR INDUCING OVULATION IN MAMMALS

#366
20140377360
2014-12-25

Composition for controlled release of physiologically active substance

#367
20140377341
2014-12-25

Cell lines and their use in encapsulated cell biodelivery

#368
20140349930
2014-11-27

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#369
20140348778
2014-11-27

Reverse thermal gels and their use in cell therapy

#370
20140315805
2014-10-23

Locally released growth factors to mediate motor recovery after stroke

#371
20140308256
2014-10-16

Methods for use of neural stem cell compositions for treatment of central nervous system lesions

#372
20140302111
2014-10-09

COMPOSITIONS AND METHODS FOR DENTAL TISSUE REGENERATION

#373
20140290647
2014-10-02

Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders

#374
20140274897
2014-09-18

METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN

#375
20140248334
2014-09-04

Peptides that target dorsal root ganglion neurons

#376
20140242087
2014-08-28

Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders

#377
20140242031
2014-08-28

Adeno-associated virus virions with variant capsid and methods of use thereof

#378
20140242007
2014-08-28

Topical preparation containing NGF for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo

#379
20140227220
2014-08-14

Method for treating chemotherapy-induced male infertility

#380
20140219953
2014-08-07

ADHESIVE CELL TISSUE GELS

#381
20140200277
2014-07-17

Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

#382
20140193409
2014-07-10

FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS

#383
20140186949
2014-07-03

Enhancing a population of insulin releasing cells using GFR α-1 agonists

#384
20140140968
2014-05-22

Mesenchymal stem cells for the treatment of CNS diseases

#385
20140088339
2014-03-27

Method and system for treatment of cardiovascular disorders

#386
20140057974
2014-02-27

Methods for therapy of neurodegenerative disease of the brain

#387
20140057837
2014-02-27

METHODS AND COMPOSITIONS FOR THE "BROWNING" OF WHITE FAT

#388
20140038887
2014-02-06

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR, OBESITY, AND OBESITY-RELATED DISEASES AND CONDITIONS

#389
20140017297
2014-01-16

Administration of growth factors for the treatment of CNS disorders

#390
20140017193
2014-01-16

Methods for treating nervous system injury and disease

#391
20130324474
2013-12-05

Variants of human GDNF

#392
20130309304
2013-11-21

COMPOUNDS AND METHODS

#393
20130302396
2013-11-14

Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones

#394
20130274186
2013-10-17

NEURTURIN MOLECULES

#395
20130273136
2013-10-17

Sustained drug delivery system

#396
20130237477
2013-09-12

Compositions and methods for increasing vascularization

#397
20130230580
2013-09-05

Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration

#398
20130224836
2013-08-29

Adeno-associated virus vector for gene transfer to nervous system cells

#399
20130190687
2013-07-25

Implantable medical devices having double walled microspheres

#400
20130178419
2013-07-11

METHOD OF TREATING PAIN BY ADMINISTRATION OF NERVE GROWTH FACTOR

#401
20130158510
2013-06-20

System and method for treatment of hemorrhagic stroke

#402
20130130981
2013-05-23

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#403
20130095060
2013-04-18

PHARMACEUTICAL COMPOSITION FOR PROMOTING ARTERIOGENESIS, AND PREPARATION METHOD AND APPLICATIONS FOR THE SAME

#404
20130078220
2013-03-28

Dopaminergic neuronal survival-promoting factors and uses thereof

#405
20130065830
2013-03-14

Amidated dopamine neuron stimulating peptide restoration of mitochondrial activity

#406
20130052245
2013-02-28

COSMETIC AND DERMATOLOGICAL FORMULATIONS OF MNTF PEPTIDES

#407
20130035670
2013-02-07

Solvent/polymer solutions as suspension vehicles

#408
20130034210
2013-02-07

Solvent/polymer solutions as suspension vehicles

#409
20130030056
2013-01-31

Methods of delivering pharmaceutical agents

#410
20130022585
2013-01-24

Regeneration and repair of neural tissue using postpartum-derived cells

#411
20120328557
2012-12-27

ADHESIVE CELL TISSUE GELS

#412
20120316112
2012-12-13

Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

#413
20120282324
2012-11-08

Methods for promoting the revascularization and reenervation of CNS lesions

#414
20120259318
2012-10-11

Solvent/polymer solutions as suspension vehicles

#415
20120258916
2012-10-11

Methods of treating chronic simple glaucoma with ophthalmic preparations based on BDNF (brain-derived neurotrophic factor)

#416
20120230941
2012-09-13

Methods for treating nervous system injury and disease

#417
20120220517
2012-08-30

Glycopegylation methods and proteins/peptides produced by the methods

#418
20120214738
2012-08-23

Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases

#419
20120208753
2012-08-16

Composition and Method for the Treatment or Prevention of Spinal Disorders III

#420
20120195865
2012-08-02

TRANSPLANTATION OF BONE MARROW STROMAL CELLS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#421
20120184492
2012-07-19

THERAPEUTIC USE OF A GROWTH FACTOR, NSG33

#422
20120184481
2012-07-19

Variants of pigment epithelium derived factor and uses thereof

#423
20120177717
2012-07-12

Sustained drug delivery system

#424
20120165255
2012-06-28

Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases

#425
20120164106
2012-06-28

Adeno-associated virus virions with variant capsid and methods of use thereof

#426
20120143272
2012-06-07

Method for treating damaged tissue of the CNS

#427
20120142591
2012-06-07

Method of treating intraoccular tissue pathologies with nerve growth factor

#428
20120122777
2012-05-17

DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP

#429
20120108518
2012-05-03

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

#430
20120083453
2012-04-05

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#431
20120082650
2012-04-05

METHODS FOR TREATING PARKINSON'S DISEASE AND OTHER DISORDERS OF DOPAMINERGIC NEURONS OF THE BRAIN

#432
20120076759
2012-03-29

Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases

#433
20120052075
2012-03-01

Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders

#434
20120027847
2012-02-02

Cell lines and their use in encapsulated cell biodelivery

#435
20120009673
2012-01-12

Mesenchymal stem cells for the treatment of CNS diseases

#436
20120009245
2012-01-12

Administration of growth factors for the treatment of CNS disorders

#437
20110319328
2011-12-29

BONE MORPHOGENETIC PROTEIN COMPOSITIONS

#438
20110288021
2011-11-24

Administration of angiocidin for the treatment of leukemia

#439
20110268710
2011-11-03

Methods of treating stroke using stem cell-like menstrual blood cells

#440
20110264077
2011-10-27

Solvent/polymer solutions as suspension vehicles

#441
20110256150
2011-10-20

Modulation of axon degeneration

#442
20110256113
2011-10-20

Method for treating diabetes using neurturin

#443
20110245798
2011-10-06

Method of treating parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen

#444
20110236457
2011-09-29

Micronized device for the delivery of biologically active molecules and methods of use thereof

#445
20110236431
2011-09-29

TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF

#446
20110217280
2011-09-08

METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS

#447
20110212055
2011-09-01

NEURODEGENERATIVE DISORDERS

#448
20110189263
2011-08-04

Peptides that target dorsal root ganglion neurons

#449
20110177170
2011-07-21

IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION

#450
20110137329
2011-06-09

Nerve regeneration employing keratin biomaterials

#451
20110124706
2011-05-26

SOCS3 Inhibition Promotes CNS Neuron Regeneration

#452
20110123497
2011-05-26

GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF

#453
20110112035
2011-05-12

Therapeutic use of a growth factor, METRNL

#454
20110105393
2011-05-05

METHODS FOR PROMOTING STEM CELL PROLIFERATION AND SURVIVAL

#455
20110104165
2011-05-05

METHOD OF UPREGULATING SORLA FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#456
20110104111
2011-05-05

Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles

#457
20110104100
2011-05-05

COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM

#458
20110071078
2011-03-24

Methods for treating neurological deficits

#459
20110064669
2011-03-17

USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS

#460
20110052711
2011-03-03

Controlled release multidrug formulations for spinal cord injury

#461
20110039916
2011-02-17

Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof

#462
20110039790
2011-02-17

Enhanced ocular neuroprotection and neurostimulation

#463
20110038832
2011-02-17

METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE

#464
20110034383
2011-02-10

CXCL12 GAMMA A CHEMOKINE AND USES THEREOF

#465
20110033463
2011-02-10

APHERESIS, ADMINISTRATION OF AGENT, OR COMBINATION THEREOF

#466
20110003741
2011-01-06

Neurturin conjugates for pharmaceutical use

#467
20100330184
2010-12-30

INJECTION VEHICLE FOR POLYMER-BASED FORMULATIONS

#468
20100311653
2010-12-09

Splice variants of GDNF and uses thereof

#469
20100303811
2010-12-02

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

#470
20100297209
2010-11-25

SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES

#471
20100297121
2010-11-25

Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists

#472
20100261654
2010-10-14

Methods for increasing vascularization

#473
20100260843
2010-10-14

Regeneration and repair of neural tissue using postpartum-derived cells

#474
20100256066
2010-10-07

ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS

#475
20100227823
2010-09-09

Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands

#476
20100216710
2010-08-26

Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis

#477
20100215722
2010-08-26

Tissue Regeneration II

#478
20100210013
2010-08-19

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#479
20100204683
2010-08-12

Therapeutic hybrid implantable devices

#480
20100184965
2010-07-22

Complex consisted of a polysaccharide and an HBP

#481
20100184656
2010-07-22

Pantropic neurotrophic factors

#482
20100183645
2010-07-22

ACTIVE OR PASSIVE IMMUNIZATION AGAINST PROAPOPTOTIC NEUROTROPHINS FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES

#483
20100172871
2010-07-08

Muller Cell Specific Gene Therapy

#484
20100144631
2010-06-10

Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof

#485
20100129435
2010-05-27

Methods and compositions for treatment of ocular neovascularization and neural injury

#486
20100125099
2010-05-20

Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene

#487
20100119491
2010-05-13

Dopaminergic neuronal survival-promoting factors and uses thereof

#488
20100093631
2010-04-15

Method of treating cravings by administration of nerve growth factor

#489
20100086997
2010-04-08

TrkB Agonists for Treating Autoimmune Disorders

#490
20100056440
2010-03-04

COMPOSITIONS AND METHODS FOR ADMINISTERING GDNF LIGAND FAMILY PROTEINS

#491
20100048456
2010-02-25

Glycopegylation methods and proteins/peptides produced by the methods

#492
20100028398
2010-02-04

CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS

#493
20100015230
2010-01-21

Bone Morphogenetic Protein Compositions

#494
20090326607
2009-12-31

Electrical stimulation method for treatment of peripheral neuropathy

#495
20090312400
2009-12-17

Methods for therapy of neurodegenerative disease of the brain

#496
20090306225
2009-12-10

Auris formulations for treating otic diseases and conditions

#497
20090304675
2009-12-10

METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#498
20090298741
2009-12-03

Trophic factor combinations for nervous system treatment

#499
20090291897
2009-11-26

METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST

#500
20090291893
2009-11-26

Compositions for the prevention and treatment of neuroinjury and methods of use thereof

#501
20090282495
2009-11-12

Neurotrophic factor MANF and uses thereof

#502
20090274752
2009-11-05

Cosmetic and dermatological formulations of MNTF peptides

#503
20090269320
2009-10-29

Variants of pigment epithelium derived factor and uses thereof

#504
20090258831
2009-10-15

TREATMENT USING NEUBLASTIN POLYPEPTIDES

#505
20090203633
2009-08-13

Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof

#506
20090203610
2009-08-13

METHODS OF TREATING OBESITY OR DIABETES USING NT-4/5

#507
20090202505
2009-08-13

Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

#508
20090191165
2009-07-30

FIBRIN GLUE COMPOSITION FOR REPAIRING NERVE DAMAGE AND METHODS THEREOF

#509
20090181008
2009-07-16

METHODS OF TREATING ALZHEIMER'S DISEASE

#510
20090156498
2009-06-18

Fusion proteins for delivery of GDNF to the CNS

#511
20090143282
2009-06-04

ENHANCED RECOVERY FOLLOWING OCULAR SURGERY

#512
20090118177
2009-05-07

USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE

#513
20090110661
2009-04-30

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

#514
20090099070
2009-04-16

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MALE ERECTILE DYSFUNCTION AND FEMALE SEXUAL AROUSAL DISORDER

#515
20090081231
2009-03-26

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE

#516
20090081213
2009-03-26

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE

#517
20090076481
2009-03-19

Therapeutic angiogenesis for treatment of the spine

#518
20090060972
2009-03-05

DEVICE AND METHOD FOR CELL GRAFTING

#519
20090048162
2009-02-19

Methods of treating neuronal disorders using MNTF peptides and analogs thereof

#520
20090011980
2009-01-08

Method of Treating Parkinson's Disease in Humans by Direct Infusion of Glial Cell-Line Derived Neurotrophic Factor Into the Zona Incerta

#521
20080299655
2008-12-04

Methods of inducing tubulogenesis and/or branching morphogenesis of kidney cell cultures

#522
20080299169
2008-12-04

Topographical Templating of Polymeric Materials Using Cellular Morphology

#523
20080293735
2008-11-27

Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes

#524
20080286323
2008-11-20

Human Therapeutic Cells Secreting Nerve Growth Factor

#525
20080286267
2008-11-20

Methods for treating nervous system injury and disease

#526
20080286250
2008-11-20

Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf

#527
20080274077
2008-11-06

Method for Treating Neurological Disorders

#528
20080261879
2008-10-23

Method of inducing and maintaining neuronal cells

#529
20080260702
2008-10-23

Treatment of Retinopathies Using Gfra3 Agonists

#530
20080241106
2008-10-02

Method for Preventing and Treating Diabetes Using Neurturin

#531
20080234197
2008-09-25

Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)

#532
20080214458
2008-09-04

Synapse-specific proteins in glomeruli

#533
20080213219
2008-09-04

Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

#534
20080206287
2008-08-28

Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands

#535
20080194488
2008-08-14

Orally active peptides that prevent cell damage and death

#536
20080193409
2008-08-14

Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy

#537
20080187522
2008-08-07

Enhancing a population of insulin releasing cells using GFR-A1 agonists

#538
20080176953
2008-07-24

Methods and compositions for treatment of ocular neovascularization and neural injury

#539
20080175829
2008-07-24

METHOD FOR INDUCING NEURAL DIFFERENTIATION

#540
20080152689
2008-06-26

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

#541
20080146498
2008-06-19

Diagnostic Agent For Ischemic Heart Disease Risk Group

#542
20080138415
2008-06-12

COMPOSITION AND METHOD FOR PRODUCING COMPOSITION FOR CONSTRUCTING TISSUE, AND TISSUE CONSTRUCT

#543
20080132464
2008-06-05

Selective induction of apoptosis to treat ocular disease by expression of PEDF

#544
20080132451
2008-06-05

MODULATION OF POLYSIALYLATED NEURAL ADHESION MOLECULES (PSA-NCAM) AS A REGULATOR OF OCULAR DISEASE

#545
20080131400
2008-06-05

Vector system

#546
20080108579
2008-05-08

ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION

#547
20080107632
2008-05-08

Fibrin glue composition for repairing nerve damage and methods thereof

#548
20080102101
2008-05-01

ENHANCED RECOVERY FOLLOWING OCULAR SURGERY

#549
20080102055
2008-05-01

Method for detecting candidate alzheimer's disease drug

#550
20080090765
2008-04-17

Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage

#551
20080039399
2008-02-14

Methods and systems for neural maintenance and regeneration

#552
20080039385
2008-02-14

Neublastin variants

#553
20080038237
2008-02-14

Trojan horse immunotherapy

#554
20080033403
2008-02-07

Methods and systems for neural maintenance and regeneration

#555
20080025978
2008-01-31

Method for inhibiting apoptosis through the p75 neurotrophin receptor

#556
20080015550
2008-01-17

Methods and systems for neural maintenance and regeneration

#557
20080015154
2008-01-17

Methods and systems for neural maintenance and regeneration

#558
20080004602
2008-01-03

Methods and systems for neural maintenance and regeneration

#559
20070298070
2007-12-27

Nerve regeneration employing keratin biomaterials

#560
20070275026
2007-11-29

Therapeutic use of a growth factor, NsG33

#561
20070270347
2007-11-22

Methods of Treating Constipation by Administration of Nerve Growth Factor

#562
20070264354
2007-11-15

TREATMENT OF A WOUND WITH A VASODILATOR

#563
20070254842
2007-11-01

Administration of growth factors for the treatment of CNS disorders

#564
20070253930
2007-11-01

Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin

#565
20070249554
2007-10-25

Methods for therapy of neurodegenerative disease of the brain

#566
20070248611
2007-10-25

METHODS WANTED FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST

#567
20070243160
2007-10-18

REMEDIES FOR NERVE DAMAGES

#568
20070224173
2007-09-27

Nonexpansion Protocol for Autologous Cell-Based Therapies

#569
20070218105
2007-09-20

Topical Treatment with NGF and DHA in Damaged Corneas

#570
20070207209
2007-09-06

Trophic factor combinations for nervous system treatment

#571
20070207121
2007-09-06

Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration

#572
20070178591
2007-08-02

Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient

#573
20070167362
2007-07-19

Medicines containing nerve growth factor for assisting losing weight and methods for assisting losing weight using same

#574
20070154524
2007-07-05

Micronized device for the delivery of biologically active molecules and methods of use thereof

#575
20070122381
2007-05-31

Method for regulating neuron development and maintenance

#576
20070110735
2007-05-17

Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands

#577
20070110712
2007-05-17

Method of modulating fertility in animals

#578
20070098736
2007-05-03

Injection vehicle for polymer-based formulations

#579
20070086979
2007-04-19

Methods and compositions for use in treatment of patients with autoantibody positive disease

#580
20070082848
2007-04-12

VEGF-C or VEGF-D materials and methods for treatment of neuropathologies

#581
20070078077
2007-04-05

Enhanced ocular neuroprotection and neurostimulation

#582
20070071693
2007-03-29

Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases

#583
20070060526
2007-03-15

Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

#584
20070037768
2007-02-15

Methods for therapy of neurodegenerative disease of the brain

#585
20070036767
2007-02-15

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#586
20070026485
2007-02-01

Glycopegylation methods and proteins/peptides produced by the methods

#587
20070026069
2007-02-01

Biommetic hierarchies using functionalized nanoparticles as building blocks

#588
20070015697
2007-01-18

Enhanced ocular neuroprotection and neurostimulation

#589
20070014771
2007-01-18

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#590
20070014760
2007-01-18

Enhanced recovery following ocular surgery

#591
20070009494
2007-01-11

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#592
20060282062
2006-12-14

Methods for elevating neurotrophic agents

#593
20060275290
2006-12-07

Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases

#594
20060275272
2006-12-07

Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases

#595
20060270838
2006-11-30

Pantropic neurothrophic factors

#596
20060269525
2006-11-30

Co-grafts for treating Parkinson's disease

#597
20060234376
2006-10-19

Repair and regeneration of ocular tissue using postpartum-derived cells

#598
20060222631
2006-10-05

Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

#599
20060204471
2006-09-14

Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging

#600
20060195915
2006-08-31

Novel neurotrophic factor protein and uses thereof